Latest Resources

Novel organ-on-a-chip platforms drive disease research and precision medicine development. 

In vitro transcription lays the foundation for recent advances in mRNA vaccines and therapeutics. 

Antibiotic exposure may impact tumor immunogenicity and breast cancer survival. 

Fragile mRNA molecules depend on protective carriers to transport them into cells. 

Metatranscriptomics enables researchers to peer into the microbiome to determine unique microbial functions and develop new therapeutics.

Advanced biomedical technologies deliver new possibilities for studying complex biological systems.

The complex interplay between bacteria and the tumor microenvironment informs cancer immunotherapy strategies.

Researchers determine strategies and considerations for making safe AAV-based gene therapies available.

What was once a weapon of destruction became a mainstay of cancer treatment.